ADRB2 and asthma: In a murine asthma model, chronic administration of β-blockers attenuating mucus production was associated with upregulated β2-AR level in airway epithelia, and transgenic overexpression of β2-AR in airway epithelial cells decreased bronchoconstriction and airway hyperresponsiveness [7], [47].